statistiche ricercatore

Continente	#
EU - Europa	934
NA - Nord America	728
AS - Asia	394
AF - Africa	34
SA - Sud America	18
OC - Oceania	14
Continente sconosciuto - Info sul continente non disponibili	2
Totale	2.124

Nazione	#
US - Stati Uniti d'America	676
GB - Regno Unito	391
CN - Cina	184
IT - Italia	161
DE - Germania	103
SE - Svezia	89
IN - India	56
CA - Canada	51
IE - Irlanda	36
FR - Francia	29
TR - Turchia	28
RU - Federazione Russa	26
IR - Iran	23
FI - Finlandia	19
EG - Egitto	18
KR - Corea	18
JP - Giappone	17
SG - Singapore	15
AU - Australia	13
BR - Brasile	13
HK - Hong Kong	13
NL - Olanda	13
BE - Belgio	12
UA - Ucraina	12
DK - Danimarca	10
TN - Tunisia	9
IL - Israele	8
EU - Europa	7
CH - Svizzera	6
GR - Grecia	6
TW - Taiwan	6
ID - Indonesia	5
PH - Filippine	5
VN - Vietnam	5
ES - Italia	4
IQ - Iraq	4
MA - Marocco	4
PL - Polonia	4
PE - Perù	3
RO - Romania	3
HU - Ungheria	2
PK - Pakistan	2
PT - Portogallo	2
SK - Slovacchia (Repubblica Slovacca)	2
TH - Thailandia	2
AR - Argentina	1
AT - Austria	1
CO - Colombia	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
ET - Etiopia	1
GE - Georgia	1
IS - Islanda	1
LT - Lituania	1
MX - Messico	1
MY - Malesia	1
NG - Nigeria	1
NZ - Nuova Zelanda	1
UZ - Uzbekistan	1
Totale	2.129

Nome	#
MELATONIN: A PLEIOTROPIC MOLECULE OF NATURAL ORIGIN. EVALUATION OF THE DIFFERENT THERAPEUTIC ACTIVITIES IN ANIMAL MODELS AND / OR HUMAN PATIENTS AND A STUDY OF THE METABOLIC-BIOCHEMICAL PATHWAYS RELATED TO THEM.	403
Transdermal administration of melatonin coupled to cryopass laser treatment as noninvasive therapy for prostate cancer	271
Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction	263
Melatonin : positive effects on high-risk patients with desynchronized sleep-wake rhythm	233
LNCaP Prostate Cancer Growth In Vivo : Oncostatic Effects of Melatonin as compared to Hypoxia and Reoxygenation	196
Pharmacokinetics of oral melatonin in high-risk critically ill : standard formulation vs incapsulation in solid lipid nanoparticles (SLN)	173
Novel strategies to deliver melatonin (in SLN and by cryo-laser therapy) to prostate cancer cells	173
Different routes and formulations of melatonin in critically ill patients : a pharmacokinetic randomized study	159
Novel strategies to deliver melatonin (in SLN and as cryo-laser therapy) to prostate cancer cells in vivo	148
Antitumour activity of melatonin in a mouse model of human prostate cancer : relationship with hypoxia signalling	122
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV	104
Totale	2.245

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	52	0	0	0	0	0	0	0	0	0	0	21	31
2019/2020	385	45	17	16	30	27	54	46	25	67	31	13	14
2020/2021	230	20	19	13	10	17	14	11	20	48	14	37	7
2021/2022	225	31	11	22	12	14	21	10	15	24	23	11	31
2022/2023	244	27	38	24	23	18	48	6	16	24	4	7	9
2023/2024	124	17	15	6	13	26	5	12	16	3	11	0	0
Totale													2.245

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca